AzTrials
AzTrials

FibromyalgiaPhase 2NCT01586637

Art Therapy to Treat Women With Fibromyalgia

A Phase 2 study testing Art Therapy and Walking in people with Fibromyalgia, run by Federal University of São Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Effectiveness of an art therapy program for the treatment of pain and improvements in both quality of life and body image of patients with fibromyalgia. Read more about this study

Who is it for?
Ages 18 to 65 years, women only
Conditions the study is for
Fibromyalgia
What is being tested?
Art Therapy and Walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBrazil
Study dates
Jan 2011to Jan 2012
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Classification of fibromyalgia by ACR criteria (Wolf et al, 1990)
  • Females
  • Without distinction of race
  • Age 18 to 65 years
  • Do not have changed treatment for fibromyalgia for at least 3meses
  • signing the consent form

Who cannot join

  • Other ostearticulares rheumatic and painful
  • Decompensated cardio-respiratory diseases
  • Perform physical activity more than 2x a week for more than 3 months

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Andréia Salvador Baptista

    São Paulo, São Paulo, 03237070

Other trials in Brazil

About this study

Official title: Assessment of Art Therapy Program for Women With Fibromyalgia: Randomized, Controlled, Blinded Study

Effectiveness of an art therapy program for the treatment of pain and improvements in both quality of life and body image of patients with fibromyalgia.

Read the detailed description

Fibromyalgia (FM) is a chronic non-inflammatory syndrome characterized by diffuse pain throughout the body, sleep disorder, stiffness, fatigue, depression and other psychological problems. Patients with FM feel incapable of performing the majority of activities of daily living. Medication offers only short-term benefits. Thus, it is necessary to include other measures for treatment, such as physical activity and patient education. Art therapy combine the field of psychology with artistic activities, working with therapeutic and instructive aspects as well as the potential for personal growth contained in all forms of art.

Conditions
Fibromyalgia
Being tested
Art Therapy, Walking
Keywords
Fibromyalgia, Art Therapy, Pain, Quality of life, Body Image
Medical subject headings
Fibromyalgia, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Art TherapyOther

    Also called Rehabilitation, exercise, physical therapy

    This group performed dance classes and regarding the art therapy they have art classes where they learn how to use the drawing to express feelings. The classes were twice a week.

  • WalkingOther

    Also called Rehabilitation, exercise, physical therapy

    The group walked twice a week during one hour.

Study groups in NCT01586637
Study groupRoleWhat they receive
Art TherapyExperimentalThis group performed dance classes and regarding the art therapy they have art classes where they learn how to use the drawing to express feelings. The classes were twice a week.
Receives: Other: Art Therapy
WalkingExperimentalThe group walked twice a week during one hour.
Receives: Other: Walking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain

    Evaluated with the visual analogue scale

    Measured: baseline, after 10 weeks, 20 weeks and 40 weeks

Secondary outcomes (4)
  1. Change in fibromyalgia impact

    Evaluated using the Fibromyalgia Impact Questionnaire

    Measured: Baseline, after 10, 20 and 40 weeks

  2. Change in Quality of life

    Evaluated using the SF-36 questionnaire

    Measured: Baseline, after 10, 20 and 40 weeks

  3. Change in Body image

    Evaluated using the Body Dismorphic Disorder Examination (BDDE) questionnaire

    Measured: Basline, after 10, 20 and 40 weeks

  4. Change in Functional capacity

    Evaluated using the six minute walk test

    Measured: Baseline, after 10, 20 and 40 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2012 (estimated)
  2. Study startJan 2011
  3. Primary completionJan 2012
  4. Study completionJan 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01586637
Sponsor's protocol ID
0206/10
Status last verified
Apr 2012
First submitted
16 Feb 2012
Last updated
27 Apr 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Art Therapy and Walking in people with Fibromyalgia, run by Federal University of São Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain (time frame: baseline, after 10 weeks, 20 weeks and 40 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in